A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the ...

Immune Sensitivity Links Race and Survival After Prostate ... May Be Effective Without Hormone Therapy for Some Men With Biochemically Recurrent Prostate Cancer Aug. 22, 2024 — The anti-cancer ...

Prostate cancer is a health issue that impacts individuals worldwide, and choosing the best treatment can be difficult, given ...

The intended therapeutic effect of gonadotropin-releasing-hormone (GnRH) agonists is hypogonadism, which is a leading cause of osteoporosis in men. Observations are consistent with this effect ...

Advanced prostate cancer is cancer that has spread beyond the prostate to distant parts of the body. It is also called ...

Discover the study supports the potential of neoadjuvant androgen deprivation therapy as an adjunctive therapy in HRLPC.

In the last few years, large Phase III trials showed improvements in survival and ... is the mainstay of therapy of advanced prostate cancer treatment, but the cure rate is low and patients ...

Treating Prostate ... cancer without accompanying hormone therapy for men who have mutations in genes such as BRCA2, according to ... Precision Therapy for Metastatic Prostate Cancer Improves ...

A study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk ...

Prostate cancer ranks among the most common health challenges men face worldwide. While medical advances continue to improve treatment outcomes, the e ...

Bayer seeks China NMPA marketing authorization for ARi darolutamide in combo with ADT in patients with metastatic hormone-sensitive prostate cancer: Berlin Wednesday, January 8, 2 ...